We know Pericoach is aimed at PF conditions other than UI, and Pelvic Organ Prolapse (POP), another nasty malady, I assume is the main other.
To be conservative it might be best not to factor this segment; however I see similarities with the UI market, suspect it could be a good earner and, if any of us were conservative 'investors' we wouldn't be here.
It effects between .25-.42% of the adult population; 1% of the >65's mainly women. The only treatment for pop is expensive surgery. Mesh is used and there are twice as many suffering related complaints compared to mesh used in UI surgery.
See the similarities? Additionally post surgery there is a 30-40% rate of recurring issues.
To my mind in the least this should be another strong driver for professionals to recommend our lead product.
ALT Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
